Cargando…
Role of Biomarkers in Prediction of Cardiotoxicity During Cancer Treatment
PURPOSE OF REVIEW: As cancer survivor rates improve with early screening and modern treatment options, cardiotoxicity is becoming an increasing problem. It is imperative for physicians to recognize adverse events early so that appropriate measures can be taken before advanced and permanent cardiac d...
Autores principales: | Tan, Li-Ling, Lyon, Alexander R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008350/ https://www.ncbi.nlm.nih.gov/pubmed/29923056 http://dx.doi.org/10.1007/s11936-018-0641-z |
Ejemplares similares
-
Cardiotoxicity of Contemporary Anticancer Immunotherapy
por: Dal’bo, Natalie, et al.
Publicado: (2020) -
Metabolic Aspects of Anthracycline Cardiotoxicity
por: Russo, Michele, et al.
Publicado: (2021) -
Advanced Imaging Modalities to Monitor for Cardiotoxicity
por: Seraphim, Andreas, et al.
Publicado: (2019) -
Cardiotoxicities of 5-Fluorouracil and Other Fluoropyrimidines
por: Shiga, Taro, et al.
Publicado: (2020) -
Strategies for Cardio-Oncology Care During the COVID-19 Pandemic
por: Abraham, Sonu, et al.
Publicado: (2022)